Latest Streaming News

Scott Technology aims to more than double Protein Domain revenue to NZ$165 million by FY30, leveraging global growth of its BladeStop safety bandsaw and a new Mexico distribution deal.

Ingenia Communities Group (ASX: INA) reported an 18% rise in FY26 EBIT to $193.4 million, beating guidance, while underlying EPS grew 16% to 35.8 cents. The group also extended its land lease development pipeline to 8,800 sites, underpinning future growth.

Brisbane Broncos Limited reported a 33% jump in half-year profit before tax to $11.57 million, fuelled by higher crowds, membership, and merchandise sales despite a slight dip in ARLC funding.

Terragen Holdings posted a slight increase in net loss to AUD 3.75 million for FY2026, while advancing key commercial trials and securing a $7 million equity raise to fuel growth.

Genetic Signatures narrowed its FY2026 net loss by 30% to $14 million amid a strategic overhaul, signing a key 10-year supply deal with Denmark’s Hvidovre Hospital and resetting its US market approach.

Scentre Group reported a 24.6% jump in half-year profit to $974.5 million despite an 8.3% dip in revenue, driven by strategic sales and robust leasing activity. The group upgraded its full-year FFO and distribution guidance, highlighting a confident outlook.

Jcurve Solutions (ASX:JCS) posted a significant financial turnaround in FY2026, with revenue climbing 16.3% to $13.28 million and normalised EBITDA more than doubling to $1.88 million, underpinned by disciplined cost control and recurring revenue growth.

Verbrec has landed $16 million in new contracts spanning engineering, construction, and cyber security services for gas infrastructure, reinforcing its role in Australia's energy security amid looming supply challenges.

Hawsons Iron Limited has closed its Share Purchase Plan raising $1.23 million through the issuance of 111.82 million shares at $0.011 each, accompanied by free attaching options. Directors contributed $90,000, reinforcing alignment with shareholders.

Neuren Pharmaceuticals’ partner Acadia Pharmaceuticals secured European Commission approval for DAYBU (trofinetide) to treat Rett syndrome symptoms in patients aged five and older, marking the first EU-authorised treatment for this condition.

Beforepay Group reported a 57% jump in cash NPAT to $15.7 million for FY26, driven by strong advances growth and scaling of its Personal Loans product. The company also secured a $100 million credit facility to fuel further expansion.

EVZ Limited reported a 14% revenue increase to $123.1 million and a 213% jump in net profit after tax to $3.87 million for FY2026, resuming dividends for the first time since 2010.